Authors:
Levegrun, S
Jackson, A
Zelefsky, MJ
Skwarchuk, MW
Venkatraman, ES
Schlegel, W
Fuks, Z
Leibel, SA
Ling, CC
Citation: S. Levegrun et al., Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data, INT J RAD O, 51(4), 2001, pp. 1064-1080
Authors:
Jackson, A
Skwarchuk, MW
Zelefsky, MJ
Cowen, DM
Venkatraman, ES
Levegrun, S
Burman, CM
Kutcher, GJ
Fuks, Z
Liebel, SA
Ling, CC
Citation: A. Jackson et al., Late rectal bleeding after conformal radiotherapy of prostate cancer (II):Volume effects and dose-volume histograms, INT J RAD O, 49(3), 2001, pp. 685-698
Authors:
Paris, F
Fuks, Z
Kang, A
Capodieci, P
Juan, G
Ehleiter, D
Haimovitz-Friedman, A
Cordon-Cardo, C
Kolesnick, R
Citation: F. Paris et al., Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice, SCIENCE, 293(5528), 2001, pp. 293-297
Authors:
Zelefsky, MJ
Fuks, Z
Hunt, M
Lee, HJ
Lombardi, D
Ling, CC
Reuter, VE
Venkatraman, ES
Leibel, SA
Citation: Mj. Zelefsky et al., High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer (vol 166, pg 876, 2001), J UROL, 166(5), 2001, pp. 1839-1839
Authors:
Zelefsky, MJ
Fuks, Z
Hunt, M
Lee, HJ
Lombardi, D
Ling, CC
Reuter, VE
Venkatraman, ES
Leibel, SA
Citation: Mj. Zelefsky et al., High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer, J UROL, 166(3), 2001, pp. 876-881
Authors:
Paris, F
Grassme, H
Cremesti, A
Zager, J
Fong, YM
Haimovitz-Friedman, A
Fuks, Z
Gulbin, E
Kolesnick, R
Citation: F. Paris et al., Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes, J BIOL CHEM, 276(11), 2001, pp. 8297-8305
Citation: N. Kalderon et al., Fractionated radiation facilitates repair and functional motor recovery after spinal cord transection in rat, BRAIN RES, 904(2), 2001, pp. 199-207
Authors:
Rosenzweig, KE
Mychalczak, B
Fuks, Z
Hanley, J
Burman, C
Ling, CC
Armstrong, J
Ginsberg, R
Kris, MG
Raben, A
Leibel, S
Citation: Ke. Rosenzweig et al., Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer, CANCER J, 6(2), 2000, pp. 82-87
Authors:
Morita, Y
Perez, GI
Paris, F
Miranda, SR
Ehleiter, D
Haimovitz-Friedman, A
Fuks, Z
Xie, ZH
Reed, JC
Schuchman, EH
Kolesnick, RN
Tilly, JL
Citation: Y. Morita et al., Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy, NAT MED, 6(10), 2000, pp. 1109-1114
Authors:
Zelefsky, MJ
Kelly, WK
Scher, HI
Lee, H
Smart, T
Metz, E
Schwartz, L
Fuks, Z
Leibel, SA
Citation: Mj. Zelefsky et al., Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer, J CL ONCOL, 18(9), 2000, pp. 1936-1941
Authors:
Kattan, MW
Zelefsky, MJ
Kupelian, PA
Scardino, PT
Fuks, Z
Leibel, SA
Citation: Mw. Kattan et al., Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer, J CL ONCOL, 18(19), 2000, pp. 3352-3359
Authors:
Sandhu, AS
Zelefsky, MJ
Lee, HJ
Lombardi, D
Fuks, Z
Leibel, SA
Citation: As. Sandhu et al., Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection, INT J RAD O, 48(3), 2000, pp. 643-647
Authors:
Rosenzweig, KE
Hanley, J
Mah, D
Mageras, G
Hunt, M
Toner, S
Burman, C
Ling, CC
Mychalczak, B
Fuks, Z
Leibel, SA
Citation: Ke. Rosenzweig et al., The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer, INT J RAD O, 48(1), 2000, pp. 81-87
Authors:
Levegrun, S
Jackson, A
Zelefsky, MJ
Venkatraman, ES
Skwarchuk, MW
Schlegel, W
Fuks, Z
Leibel, SA
Ling, CC
Citation: S. Levegrun et al., Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor controlprobability models, INT J RAD O, 47(5), 2000, pp. 1245-1260
Authors:
Ling, CC
Humm, J
Larson, S
Amols, H
Fuks, Z
Leibel, S
Koutcher, JA
Citation: Cc. Ling et al., Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality, INT J RAD O, 47(3), 2000, pp. 551-560
Authors:
Skwarchuk, MW
Jackson, A
Zelefsky, MJ
Venkatraman, ES
Cowen, DM
Levegrun, S
Burman, CM
Fuks, Z
Leibel, SA
Ling, CC
Citation: Mw. Skwarchuk et al., Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response, INT J RAD O, 47(1), 2000, pp. 103-113
Authors:
Zelefsky, MJ
Fuks, Z
Happersett, L
Lee, HJ
Ling, CC
Burman, CM
Hunt, M
Wolfe, T
Venkatraman, E
Jackson, A
Skwarchuk, M
Leibel, SA
Citation: Mj. Zelefsky et al., Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer, RADIOTH ONC, 55(3), 2000, pp. 241-249
Authors:
Wang, S
Guo, M
Ouyang, H
Li, XL
Cordon-Cardo, C
Kurimasa, A
Chen, DJ
Fuks, Z
Ling, CC
Li, GC
Citation: S. Wang et al., The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest, P NAS US, 97(4), 2000, pp. 1584-1588